| 臺大學術典藏 |
2020-02-14T02:50:22Z |
Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects
|
Wen-Fang Cheng;Hung C.F.;Pai S.I.;Hsu K.F.;He L.;Ling M.;Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C. |
| 臺大學術典藏 |
2020-02-14T02:50:21Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wen-Fang Cheng;Hung C.-F.;Hsu K.-F.;Chai C.-Y.;He L.;Polo J.M.;Slater L.A.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:49:49Z |
Circulating IGF system and treatment outcome in epithelial ovarian cancer
|
Chou C.-Y.; Hsu K.-F.; Cheng Y.-M.; Wu Y.-P.; WEN-FANG CHENG; Huang Y.-F.; Huang Y.-F.;Wen-Fang Cheng;Wu Y.-P.;Cheng Y.-M.;Hsu K.-F.;Chou C.-Y. |
| 臺大學術典藏 |
2020-02-14T02:49:48Z |
Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study
|
Hsu K.-F.; Chou H.-H.; Huang C.-Y.; Fu H.-C.; Chiang A.-J.; Tsai H.-W.; Chen J.-R.; WEN-FANG CHENG; Ke Y.-M.; Chang C.-C.; Chen T.-H.; Lin S.-H.; Ho C.-M. |
| 臺大學術典藏 |
2020-02-14T02:49:38Z |
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
|
Fu H.-C.;Chen J.-R.;Chen M.-Y.;Hsu K.-F.;Wen-Fang Cheng;Chiang A.-J.;Ke Y.-M.;Chen Y.-C.;Chang Y.-Y.;Huang C.-Y.;Kang C.-Y.;Kan Y.-Y.;Hsiao S.-M.;Yen M.-S.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
|
Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments
|
Wu T.-C.;Roden R.B.S.;Slater L.A.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:46Z |
Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;WEN-FANG CHENG;Hsu K.-F.;Hung C.-F.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen
|
Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
|
Wu T.-C.;Ling M.;Slater L.A.;He L.;WEN-FANG CHENG;Hung C.-F.;Hsu K.-F.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:44Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene
|
Wu T.-C.;Ling M.;Rice C.M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:42Z |
Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects
|
Ling M.; Wu T.C.; Wu T.C.;Ling M.;He L.;Hsu K.F.;Pai S.I.;Hung C.F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L. |
| 臺大學術典藏 |
2020-02-06T05:22:40Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wu T.-C.;Ling M.;Slater L.A.;Polo J.M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:02Z |
Circulating IGF system and treatment outcome in epithelial ovarian cancer
|
Chou C.-Y.;Hsu K.-F.;Cheng Y.-M.;Wu Y.-P.;WEN-FANG CHENG;Huang Y.-F.; Huang Y.-F.; WEN-FANG CHENG; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y.; Huang Y.-F.; WEN-FANG CHENG; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
|
Yen M.-S.;Hsiao S.-M.;Kan Y.-Y.;Kang C.-Y.;Huang C.-Y.;Chang Y.-Y.;Chen Y.-C.;Ke Y.-M.;Chiang A.-J.;WEN-FANG CHENG;Hsu K.-F.;Chen M.-Y.;Chen J.-R.;Fu H.-C.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. |
| 國立成功大學 |
2020 |
An integrated microfluidic system for rapid, automatic and high-throughput staining of clinical tissue samples for diagnosis of ovarian cancer
|
Huang, S.-P.;Chuang, Y.-J.;Lee, W.-B.;Tsai, Y.-C.;Lin, C.-N.;Hsu, K.-F.;Lee, G.-B. |
| 國立成功大學 |
2020 |
An integrated microfluidic system for continuous selection of aptamers by using tissue samples
|
Liu, W.-T.;Lee, W.-B.;Tsai, Y.-C.;Hung, L.-Y.;Fu, C.-Y.;Chuang, Y.-J.;Hsu, K.-F.;Lee, G.-B. |
| 國立成功大學 |
2019 |
Downregulated salt-inducible kinase 3 expression promotes chemoresistance in serous ovarian cancer via the ATP‐binding cassette protein ABCG2
|
Liang, Y.-L.;Wu, C.-H.;Kang, C.-Y.;Lin, C.-N.;Shih, N.-Y.;Lin, S.-H.;Chen, Y.-C.;Hsu, K.-F. |
| 國立成功大學 |
2019 |
A microfluidic platform for diagnosis of ovarian clear cell carcinoma via quantification of fxyd2 gene
|
Liu, T.-H.;Lin, C.-N.;Hsu, K.-F.;Lee, G.-B. |
| 國立成功大學 |
2019 |
Microfluidic systems for fast and accurate diagnosis of ovarian cancers
|
Tsai, Y.-C.;Liu, W.-T.;Haung, S.-P.;Lee, W.-B.;Chuang, Y.-J.;Hsu, K.-F.;Lee, G.-B. |
| 臺大學術典藏 |
2018-09-10T14:49:29Z |
Epidemiology of orthopedic fractures and other injuries among inpatients admitted due to traffic accidents: A 10-year nationwide survey in Taiwan
|
NIEN-TZU CHANG; REN-HAO PAN; DACHEN CHU; KUO-FANG HSU; YUAN-NIAN HSU; JIN-CHYR HSU; LIN-YU TSENG; NAN-PING YANG; Pan, R.-H.;Chang, N.-T.;Chu, D.;Hsu, K.-F.;Hsu, Y.-N.;Hsu, J.-C.;Tseng, L.-Y.;Yang, N.-P. |
| 臺大學術典藏 |
2018-09-10T08:50:11Z |
Complex chromosome rearrangement 46,XY, der(9)t(Y;9)(q12;p23) in a girl with sex reversal and mental retardation
|
Lee, I.-W.;Chou, Y.-Y.;Hsu, K.-F.;Chou, P.-Y.;Chen, M.;Kuo, P.-L.;Lin, S.-J.; MING CHEN |
| 臺大學術典藏 |
2018-09-10T08:19:47Z |
Comparing hepatic resection and transarterial chemoembolization for barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma: Change for treatment of choice?
|
Lin, C.-T.;Hsu, K.-F.;Chen, T.-W.;Yu, J.-C.;Chan, D.-C.;Yu, C.-Y.;Hsieh, T.-Y.;Fan, H.-L.;Kuo, S.-M.;Chung, K.-P.;Hsieh, C.-B.; KUO-PIAO CHUNG |
| 國立成功大學 |
2018 |
Clinicopathologic features and treatment outcomes in patients with stage I, high-risk histology or high-grade endometrial cancer after primary staging surgery: A Taiwanese gynecologic oncology group study
|
Yen, M.-S.;Chen, T.-H.;Ke, Y.-M.;Hsu, K.-F.;Chen, J.-R.;Yu, M.-H.;Fu, H.-C.;Huang, C.-Y.;Chiang, A.-J.;Chen, Chen C.-Y.;Hsiao, S.-M.;Kan, Y.-Y.;Liu, F.-S. |
